187 related articles for article (PubMed ID: 2401166)
41. A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial.
Vogler WR; Winton EF; Gordon DS; Raney MR; Go B; Meyer L
Blood; 1984 May; 63(5):1039-45. PubMed ID: 6201211
[TBL] [Abstract][Full Text] [Related]
42. [Effects of alternating as well as long-term intensive polychemotherapy in the remission-maintaining treatment of patients with acute myelocytic leukemia].
Hansz J; Bajko G; Woźny T; Drozdowska D
Pol Arch Med Wewn; 1992 Feb; 87(2):127-33. PubMed ID: 1523139
[TBL] [Abstract][Full Text] [Related]
43. Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factors.
Weinstein H; Grier H; Gelber R; Camitta B; Link M; Delorey M; Price K
Haematol Blood Transfus; 1987; 30():88-92. PubMed ID: 3476388
[No Abstract] [Full Text] [Related]
44. Intensive chemotherapy for acute myelogenous leukemia.
Gale RP; Foon KA; Cline MJ; Zighelboim J
Ann Intern Med; 1981 Jun; 94(6):753-7. PubMed ID: 6940466
[TBL] [Abstract][Full Text] [Related]
45. [Comparison of conventional chemotherapy and short-term intensive chemotherapy in adult acute myeloid leukemia].
Ohshima T
Rinsho Ketsueki; 1989 Aug; 30(8):1175-7. PubMed ID: 2601028
[TBL] [Abstract][Full Text] [Related]
46. Second long-term remission achieved with low-dose Ara-C in children with relapsed acute nonlymphoblastic leukemia.
Miniero R; Saracco P; Cordero di Montezemolo L; Fiandino G; Comelli A; Madon E
Pediatr Hematol Oncol; 1987; 4(3):273-6. PubMed ID: 3152932
[No Abstract] [Full Text] [Related]
47. Vincristine (NSC-67574), cytosine arabinoside (NSC-63878), 6 thioguanine (NSC-752) and daunorubicin (NSC-82151) (VAT-D): a pilot study of combination chemotherapy for remission induction in acute myeloid leukemia in adults.
Sartiano GP; Pfrimmer WJ; Turner AR
Med Pediatr Oncol; 1978; 4(3):205-12. PubMed ID: 277748
[TBL] [Abstract][Full Text] [Related]
48. [Evaluation of 58 patients with acute leukemia].
Sasaki A; Tsukaguchi M
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1303-7. PubMed ID: 1503484
[TBL] [Abstract][Full Text] [Related]
49. [Low-dose ARA-C and HOAAP regimen in the treatment of adult acute nonlymphocytic leukemia: analysis of 59 cases].
Dong ZR; Yao EG; Xu SR
Zhonghua Nei Ke Za Zhi; 1988 May; 27(5):300-2, 327. PubMed ID: 3197499
[No Abstract] [Full Text] [Related]
50. Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype.
Mi Y; Xue Y; Yu W; Liu S; Zhao Y; Meng Q; Bian S; Wang J
Leuk Lymphoma; 2008 Mar; 49(3):524-30. PubMed ID: 18297530
[TBL] [Abstract][Full Text] [Related]
51. Therapy of acute myelogenous leukemia in adults.
Petti MC; Broccia G; Caronia F; Di Raimondo F; Fioritoni G; Ladogana S; Leone G; Liso V; Musso M; Neri A
Haematol Blood Transfus; 1990; 33():249-53. PubMed ID: 2182417
[No Abstract] [Full Text] [Related]
52. Remission induction with cytarabine and daunorubicin with or without 6-thioguanine in adult patients with acute myelocytic leukemia.
Nowrousian MR; Pfeiffer R; Schaefer UW; Osieka R; Niederle N; Anders C; Schmidt CG
Haematol Blood Transfus; 1987; 30():352-5. PubMed ID: 3305206
[No Abstract] [Full Text] [Related]
53. Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.
Witteveen EO; Verdonck LF; Nieuwenhuis HK; Dekker AW
Haematol Blood Transfus; 1990; 33():309-13. PubMed ID: 2323635
[No Abstract] [Full Text] [Related]
54. [Chemotherapy of adult ANLL].
Kyo T; Maehama S
Rinsho Ketsueki; 1989 Aug; 30(8):1157-62. PubMed ID: 2601024
[TBL] [Abstract][Full Text] [Related]
55. Selective use of daunorubicin for remission-induction chemotherapy in acute non-lymphoblastic leukemia.
Shaikh BS; Dougherty JB; Hamilton RW; Ballard JO; Patel SB; Gevirtz NR; Eyster ME
Cancer; 1980 Oct; 46(8):1731-4. PubMed ID: 6932996
[TBL] [Abstract][Full Text] [Related]
56. Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia.
Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Bodey GP; Freireich EJ
Cancer; 1986 Oct; 58(8):1603-8. PubMed ID: 3463390
[TBL] [Abstract][Full Text] [Related]
57. Intensive treatment of acute leukemia in adults 70 years of age and older.
Walters RS; Kantarjian HM; Keating MJ; Estey EH; McCredie KB; Freireich EJ
Cancer; 1987 Jul; 60(2):149-55. PubMed ID: 3474052
[TBL] [Abstract][Full Text] [Related]
58. Chemotherapy of adult acute myeloid leukaemia.
Suri R; Kueh YK; Han P; Tan YO
Ann Acad Med Singap; 1990 Mar; 19(2):175-7. PubMed ID: 2346291
[TBL] [Abstract][Full Text] [Related]
59. [The efficacy and safety of HAA regimen as induction chemotherapy in 150 newly diagnosed acute myeloid leukemia].
Song YP; Tong Y; Qian WB; Mai WY; Meng HT; Qian JJ; Tong HY; Huang J; Mao LP; Xu WL; Jin J
Zhonghua Nei Ke Za Zhi; 2011 Jan; 50(1):48-51. PubMed ID: 21418889
[TBL] [Abstract][Full Text] [Related]
60. Short-term therapy for acute myelogenous leukemia.
Rohatiner AZ; Gregory WM; Bassan R; Barnett MJ; Waxman J; Richards MA; Ganesan TS; Tucker J; Malik ST; Biruls R
J Clin Oncol; 1988 Feb; 6(2):218-26. PubMed ID: 3422261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
